Merck (MRK) Accounts Payables (2009 - 2026)

Merck (MRK) has reported Accounts Payables for 18 consecutive years, with $3.8 billion the latest figure, recorded in Q2 2026.

• On a quarterly basis, Accounts Payables fell 1.67% year-over-year to $3.8 billion in Q2 2026; TTM through Jun 2026 was $3.8 billion, a 1.67% decrease from a year earlier, with the FY2025 full-year figure at $4.4 billion, up 7.97% from the prior year.
• Accounts Payables was $3.8 billion for Q2 2026 at Merck, down from $3.9 billion in the prior quarter.
• Over five years, Accounts Payables peaked at $4.4 billion in Q4 2025 and troughed at $3.4 billion in Q3 2022.
• A 5-year average of $3.8 billion and a median of $3.7 billion in 2022 frame the typical range for Accounts Payables.
• Across the five-year window, Accounts Payables decreased 10.65% in 2022 and advanced 15.64% in 2025, its largest moves.
• Over 5 years, Accounts Payables stood at $4.3 billion in 2022, then dropped by 8.02% to $3.9 billion in 2023, then rose by 4.0% to $4.1 billion in 2024, then advanced by 7.97% to $4.4 billion in 2025, then dropped by 13.1% to $3.8 billion in 2026.
• The last three Accounts Payables figures came in at $3.8 billion (Q2 2026), $3.9 billion (Q1 2026), and $4.4 billion (Q4 2025), per Business Quant data.